Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation

Cancer Research

Volumn 65, Issue 3, 2005, Pages 939-947

  Yang, Jinbo ^a   Chatterjee Kishore, Moitreyee ^a,c   Staugaitis, Susan M ^a   Nguyen, Hannah ^a,d   Schlessinger, Karni ^b   Levy, David E ^b   Stark, George R ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

^d METHYLGENE INC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 6; ONCOPROTEIN; STAT3 PROTEIN; TYROSINE;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MAMMARY GLANDS, HUMAN; MICE; MONOMERIC GTP-BINDING PROTEINS; NEOPLASMS; ONCOGENES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 13444309088     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995;64:621-51.
2. Raz R, Durbin JE, Levy DE. Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors. J Biol Chem 1994;269:24391-5.
3. Minami M, Inoue M, Wei S, et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci U S A 1996;93:3963-6.
4. Nakajima K, Yamanaka Y, Nakae K, et al. A central role for STAT3 in IL-6 induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 1996;15:3651-8.
5. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. STAT3 as an oncogene. Cell 1999;98:295-303.
6. Ning ZQ, Li J, McGuinness M, Arceci RJ. STAT3 activation is required for Asp (816) mutant c-Kit induced tumorigenicity. Oncogene 2001;20:4528-36.
7. Catlett-Falcone R, Dalton WS, Jove R. STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription. Curr Opin Oncol 1999;11:490-6.
8. Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 2000;19:2496-504.
9. Cao X, Tay A, Guy GR, Tan YH. Activation and association of STAT3 with Src in v-Src-transformed cell lines. Mol Cell Biol 1996;16:1595-603.
10. Yu CL, Meyer DJ, Campbell GS, et al. Enhanced DNA-binding activity of a STAT3-related protein in cells transformed by the Src oncoprotein. Science 1995;269:81-3.
11. Garcia R, Bowman TL, Niu G, et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001;20:2499-513.
12. Reddy MVR, Chaturvedi P, Reddy EP. Src kinase mediated activation of STAT3 plays an essential role in the proliferation and oncogenicity of human breast, prostate and ovarian carcinomas. Proc AACR 1999;40:376.
13. Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC. Interleukin-6 induces prostate cancer cell growth accompanied by activation of STAT3 signaling pathway. Prostrate 2000;42:239-22.
14. Weissenberger J, Loeffler S, Kappeler A, et al. IL-6 is required for glioma development in a mouse model. Oncogene 2004;23:3308-16.
15. Chatterjee-Kishore M, Wright KL, Ting JP, Stark GR. How STAT1 mediates constitutive gene expression: a complex of unphosphorylated STAT1 and IRF1 supports transcription of the LMP2 gene. EMBO J 2000;19:4111-22.
16. Lee CK, Raz R, Gimeno R, et al. STAT3 is a negative regulator of granulopoiesis but is not required for GCSF-dependent differentiation. Immunity 2002;17:63-72.
17. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc Natl Acad Sci U S A 1998;95:15623-8.
18. Wagner BJ, Hayes TE, Hoban CJ, Cochran BH. The SIF binding element confers sisPDGF inducibility onto the c-fos promoter. EMBO J 1990;9:4477-84.
19. Shen X, Hong F, Nguyen VA, Gao B. IL-10 attenuates IFN-α-activated STAT1 in the liver: involvement of SOCS2 and SOCS3. FEBS Lett 2000;480:132-6.
20. Kiuchi N, Nakajima K, Ichiba M, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med 1999;189:63-73.
21. Yang E, Lerner LR, Besser D, Darnell JE Jr. Independent and cooperative activation of chromosomal c-fos promoter by STAT3. J Biol Chem 2003;278:15794-9.
22. Niu G, Bowman T, Huang M, et al. Roles of activated Src and STAT3 signaling in melanoma tumor cell growth. Oncogene 2002;21:7001-10.
23. Zhang SY, Liu SC, Johnson DG, Klein-Szanto AJ. E2F1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res 2000;60:5972-6.
24. Banerjee SK, Weston AP, Zoubine MN, Campbell DR, Cherian R. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma: relationship to cell death, proliferation, and transformation. Am J Pathol 2000;156:217-25.
25. Narimatsu M, Maeda H, Itoh S, et al. Tissue-specific autoregulation of the STAT3 gene and its role in interleukin-6-induced survival signals in T cells. Mol Cell Biol 2001;19:6615-25.
26. Wong LH, Sim H, Chatterjfee-Kishore M, et al. Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1. J Biol Chem 2002;277:19408-17.
27. Becker S, Groner B, Muller CW. Three-dimensional structure of the STAT3 β homodimer bound to DNA. Nature 1998;394:145-51.
28. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 1998;93:827-39.
29. Horvath CM, Stark GR, Kerr IM, Darnell JE Jr. Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex. Mol Cell Biol 1996;16:6957-64.
30. Chung CD, Liao J, Liu B, et al. Specific inhibition of STAT3 signal transduction by PIAS3. Science 1997;278:1803-15.
31. Lee RJ, Albanese C, Fu M, et al. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol Cell Biol 2000;20:672-83.
32. Ohtani K, DeGregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci U S A 1995;92:12146-50.
33. Onishi T, Zhang W, Cao X, Hruska K. The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors. J Bone Miner Res 1997;12:1596-605.
34. Lukas C, Sorensen CS, Kramer E, et al. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature 1999;401:815-8.
35. Quilliam LA, Castro AF, Rogers-Graham KS, Martin CB, Der CJ, Bi C. M-RasR-Ras3, a transforming ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6. J Biol Chem 1999;274:23850-7.
36. Ehrhardt GR, Leslie KB, Lee F, Wieler JS, Schrader JW. M-Ras, a widely expressed 29-kD homologue of p21 Ras: expression of a constitutively active mutant results in factor-independent growth of an interleukin-3-dependent cell line. Blood 1999;94:2433-44.
37. Meyer T, Gavenis K, Vinkemeier U. Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3. Exp Cell Res 2002;272:45-55.
38. Turkson J, Ryan D, Kim JS, et al. Phosphotyrosyl peptides block STAT3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 2001;276:45443-55.